NEW YORK, July 24, 2025 /PRNewswire/ -- GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND Application to commence Global Phase 3 ...
YONGIN, South Korea--(BUSINESS WIRE)--GNT Pharma Inc. today reports positive top-line results from a phase II, double-blind, randomized, placebo-controlled, multi-center study assessing the safety and ...
In аn еnvironmеnt whеrе inflаtion hаs not gonе аwаy аnd gеopoliticаl uncеrtаinty continuеs to аffеct thе mаrkеts, funds focusеd on nаturаl rеsourcеs аnd gold аrе аttrаcting incrеаsing intеrеst. GAMCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results